US Stock MarketDetailed Quotes
EFTR eFFECTOR Therapeutics
- 0.059
- +0.004+6.55%
15min DelayTrading Jul 22 12:44 ET
275.68KMarket Cap-4P/E (TTM)
0.059High0.052Low16.31KVolume0.054Open0.055Pre Close872.01Turnover0.35%Turnover RatioLossP/E (Static)4.70MShares20.39552wk High0.33P/B273.10KFloat Cap0.03252wk Low--Dividend TTM4.66MShs Float1010.500Historical High--Div YieldTTM12.00%Amplitude0.032Historical Low0.053Avg Price1Lot Size
About eFFECTOR Therapeutics Company
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Solana Beach, CA.
Company Profile
SymbolEFTR
Company NameeFFECTOR Therapeutics
Listing DateMar 1, 2021
Founded2012
CEOMr. Craig R. Jalbert
MarketPink Market
Employees14
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address142 North Cedros Avenue,Suite B
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-8215
Websitehttp://www.effector.com
Company Executives
- Name
- Position
- Salary
- Craig R. Jalbert
- Chief Executive Officer, President, Director, Principal Financial Officer, Principal Accounting Officer, Treasurer and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg